Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Tryptamine Therapeutics Limited

TYP
Current price
0.019 AUD +0.001 AUD (+5.56%)
Last closed 0.019 AUD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange Australian Securities Exchange
Capitalization 26 980 438 AUD
Yield for 12 month +90.00 %
1Y
3Y
5Y
10Y
15Y
TYP
21.11.2021 - 28.11.2021

Tryptamine Therapeutics Limited, a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. Tryptamine Therapeutics Limited is based in Camberwell, Australia. Address: 697 Burke Road, Camberwell, VIC, Australia, 3124

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+610 379 AUD

Last Year

+98 410 AUD

Current Quarter

Last Quarter

Current Year

+610 379 AUD

Last Year

+98 410 AUD

Current Quarter

Last Quarter

Key Figures TYP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio
Return On Assets TTM -367.1 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price
Revenue TTM
Book Value
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share
Diluted Eps TTM
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TYP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TYP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:2.5
Payout Ratio
Last Split Date 15.04.2024
Dividend Date

Stock Valuation TYP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA
Price Book MRQ

Financials TYP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TYP

For 52 weeks

0.0079 AUD 0.027 AUD
50 Day MA 0.024 AUD
Shares Short Prior Month
200 Day MA 0.014 AUD
Short Ratio
Shares Short
Short Percent